Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
WT1 126-134 peptide vaccine
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
1 to 74
Sponsor:
NCI
Protocol IDs:
080051
, 08-C-0051, NCT00923910
2.
WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
HaemaCBFWT102
, Carreras 04/25f, NCT00153582
3.
Phase II Study of WT1 and PR1 Peptide Vaccines and Sargramostim (GM-CSF) in Patients With Low-Risk Myeloid Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 85
Sponsor:
NHLBI
Protocol IDs:
NHLBI-07-H-0159
, 07-H-0159, NCT00499772
4.
WT1 Peptid Vaccination in Carcinomas
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
HaemaCBFWT104
, EU, NCT00153608
5.
Safety of Peptide Vaccination for Patients with Myelodysplastic Syndrome
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 to 85
Sponsor:
NHLBI
Protocol IDs:
060062
, 06-H-0062, NCT00270452
6.
A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, and B Cell Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
BB-IND 13254
, NCT00672152
Select All on Page
Help with Results
